Kieffer Tara Lynn 4
4 · ENANTA PHARMACEUTICALS INC · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Kieffer Tara Lynn
Chief Product Strategy Officer
Transactions
- Sale
Common Stock
[F1][F2]2024-06-17$12.33/sh−7,266$89,590→ 32,341 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2024.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.54, inclusive.
Signature
/s/ Paul J. Mellett as attorney-in-fact|2024-06-17